NIDCR's Summer 2020 E-Newsletter
Having trouble viewing this email? View it as a Web page. NIDCR's Summer 2020 E-Newsletter In this issue: NIDCR News Funding Opportunities NIH/HHS News Funding Notices Science Advances Subscribe to NICDR News Grantee News   NIDCR News NIDCR Announces Availability of COVID-19 Research Funding On May 5, NIDCR issued two Notices of Special Interest highlighting the urgent need for research on coronavirus disease 2019. This research may be conducted either via the National Dental PBRN infrastructure orÂ...
Source: NIDCR Science News - June 4, 2020 Category: Dentistry Source Type: news

UCLA scientists invent nanoparticle that could improve treatment for bone defects
In test with mice, the sterosome activated bone regeneration was activated without needing additional drugsBrianna Aldrich |April 22, 2020A team of biomaterials scientists and dentists at theUCLA School of Dentistry has developed a nanoparticle that, based on initial experiments in animals, could improve treatment for bone defects.A paper describing the advance is published today in the journal Science Advances. Bone defects, which can be caused by traumatic injury, infection, osteoporosis or the removal of tumors, are difficult for orthopedic surgeons to treat. And the need for bone grafts are becoming more common thanks ...
Source: Dental Technology Blog - April 30, 2020 Category: Dentistry Source Type: news

UCLA scientists invent nanoparticle that could improve treatment for bone defects
A team of biomaterials scientists and dentists at theUCLA School of Dentistry has developed a nanoparticle that, based on initial experiments in animals, could improve treatment for bone defects.A paper describing the advance is published today in the journal Science Advances.Bone defects, which can be caused by traumatic injury, infection, osteoporosis or the removal of tumors, are difficult for orthopedic surgeons to treat. And the need for bone grafts are becoming more common thanks in part to our aging population: Bone injuries are particularly prevalent among the elderly.Today, the standard treatment for bone defects ...
Source: UCLA Newsroom: Health Sciences - April 22, 2020 Category: Universities & Medical Training Source Type: news

CDC: 2009 to 2017 Saw Increase in Oral Cavity, Pharynx Cancers
FRIDAY, April 17, 2020 -- From 2007 to 2016, the incidence of cancers of the oral cavity and pharynx combined increased, according to research published in the April 17 issue of the U.S. Centers for Disease Control and Prevention Morbidity and... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 17, 2020 Category: Pharmaceuticals Source Type: news

Trends in Incidence of Cancers of the Oral Cavity and Pharynx --- United States 2007--2016
From 2007 to 2016, incidence of cancers of the oral cavity and pharynx combined increased. The increase could be driven by increases in human papillomavirus-associated cancers. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - April 16, 2020 Category: American Health Tags: Cancer HPV-Associated Cancers MMWR Morbidity & Mortality Weekly Report Oral Cancer Source Type: news

Immunotherapy Tested in'Notoriously Difficult' Oral Cancers Immunotherapy Tested in'Notoriously Difficult' Oral Cancers
A short course of single-agent or combination immunotherapy leads to good tumor responses in oral cavity cancer and does not delay potentially curative surgery.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 2, 2020 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Pre-operative immunotherapy triggers encouraging response in oral cancers
(American Society for Radiation Oncology) A new clinical trial suggests that immunotherapy given before other treatments for oral cavity cancers can elicit an immune response that shrinks tumors, which could provide long-term benefit for patients. In the randomized trial, two neoadjuvant doses of nivolumab given with or without ipilimumab led to complete or partial tumor shrinkage in most cases and did not delay any patients from continuing on to standard treatment. Findings will be presented at the 2020 Multidisciplinary Head and Neck Cancers Symposium. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 27, 2020 Category: Cancer & Oncology Source Type: news

Bright idea in dentist's office leads to innovative smoking cessation project
Results from this study recently published online in Addiction found primary care physicians providing smokers with a free, two week starter kit of nicotine replacement therapy (NRT) increased quit attempts While sitting in the dentist ' s office, Hollings Cancer Center researcher Matthew Carpenter, Ph.D., of the Medical University of South Carolina, had a bright idea. As he received his goody bag with dental hygiene products, he wondered why not conduct a study and have primary care providers do the same thing for their patients who use tobacco. The bags would contain educational material, free lozenges and tobacco ces...
Source: Dental Technology Blog - February 12, 2020 Category: Dentistry Source Type: news

Oral diseases: a global public health challenge
The Lancet Published:July 20, 2019DOI:https://doi.org/10.1016/S0140-6736(19)31146-8 Oral diseases are among the most prevalent diseases globally and have serious health and economic burdens, greatly reducing quality of life for those affected. The most prevalent and consequential oral diseases globally are dental caries (tooth decay), periodontal disease, tooth loss, and cancers of the lips and oral cavity. In this first of two papers in a Series on oral health, we describe the scope of the global oral disease epidemic, its origins in terms of social and commercial determinants, and its costs i...
Source: Dental Technology Blog - July 22, 2019 Category: Dentistry Source Type: news

Oral cavity reconstruction: Mayo Clinic Radio Health Minute
Surgery to treat oral cancers-- cancer of the mouth, tongue and jaw--can be disfuguring and affect the way you speak or eat. In this Mayo Clinic Radio Health Minute,?Dr. Kevin Arce, an oral and maxillofacial surgeon at Mayo Clinic, discusses?reconstructive surgery for oral cancer patients. To listen, click the link below. Oral cavity reconstruction (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 15, 2019 Category: Databases & Libraries Source Type: news

Cochrane's 30 under 30: Meisser Madera
Cochrane is made up of  13,000 members and over 50,000 supporters come from more than 130 countries, worldwide. Our volunteers and contributors are researchers, health professionals, patients, carers, people passionate about improving health outcomes for everyone, everywhere.Cochrane is an incredible community of people who all play their part in improving health and healthcare globally. We believe that by putting trusted evidence at the heart of health decisions we can achieve a world of improved health for all.  Many  of our contributors are young people working with Cochrane as researchers, citizen scientists...
Source: Cochrane News and Events - April 3, 2019 Category: Information Technology Authors: Lydia Parsonson Source Type: news

Lymph node ratio may predict who lives and dies from oral cavity cancer
(University of Colorado Anschutz Medical Campus) Patients with lymph node ratio greater than 10 percent had about 2.5 times greater risk of cancer recurrence and 2.7 times greater risk of death than patients with LNR below 10 percent. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 6, 2018 Category: Cancer & Oncology Source Type: news

Head and Neck Cancer | Medscape Head and Neck Cancer | Medscape
Head and neck cancer, which includes cancers of the larynx, nasal passages, oral cavity, pharynx, salivary glands, and thyroid, accounts for 3% of all malignancies in the United States. (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 9, 2018 Category: Consumer Health News Tags: Resource Center Source Type: news

New oral hygiene care regimen reduces postoperative oral bacteria count and number of days with elevated fever in ICU patients with esophageal cancer.
J Oral Sci. 2018 Aug 30. doi: 10.2334/josnusd.17-0381. [Epub ahead of print]AbstractUsing a controlled pre/post study design, we investigated the effects of professional mechanical cleaning of the oral cavity with benzethonium chloride, interdental brushes, and hydrogen peroxide on the number of oral bacteria and postoperative complications among esophageal cancer patients in an intensive care unit. Before surgery, 44 patients with esophageal cancer were recruited at Okayama Hospital from January through August 2015. The control group (n = 23) received routine oral hygiene care in the intensive care unit. The intervention ...
Source: Dental Technology Blog - September 20, 2018 Category: Dentistry Source Type: news

Lip and Oral Cavity Cancer
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 10, 2018 Category: General Medicine Source Type: news